Social science: Include social equity in California Biohub
By Science FARE (Feminist Anti-Racist Equity) Collective: Jessica Cussins, Kate Weatherford Darling, Ugo Edu, Laura Mamo, Jenny Reardon & Charis Thompson,
Nature
| 10. 19. 2016
We have an idea for philanthropists Priscilla Chan and Mark Zuckerberg, who last month announced their first major investment in basic science: US$600 million for a Biohub in San Francisco, California.
They aspire to 'advance human potential and promote equality' (https://chanzuckerberg.com). As members of the Science FARE (Feminist Anti-Racist Equity) collective, we suggest that 5–7% of the Biohub's health-research budget should be used to design and monitor goals of justice and equality from the outset. Otherwise, social inequalities could limit the project's potential.
Innovative social scientists will need to work with bench scientists, engineers and clinical researchers. Health research should include trained people from all social backgrounds and a variety of disciplines.
The affordability of treatments and access to them is crucial, irrespective of class, gender, race or disabilities. Building equality into Biohub's founding architecture will allow it to be tackled simultaneously with disease eradication, mitigating the uneven social distribution of health care in San Francisco's Bay Area and beyond.
Image via C-Z BioHub
Related Articles
By Jessica Riskin, Los Ángeles Review of Books | 03.24.2026
This is the second part of the 14th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. You can read the...
By Jessica Riskin, Los Ángeles Review of Books | 03.23.2026
This is the first part of the 14th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by...
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...